
Amid protests, quota cuts, and tariff threats, panel set to rule on snow crab prices
Amid quota cuts, protests, a court challenge and the constant uncertainty of a mercurial U.S. president, parties for both sides of the lucrative Newfoundland and Labrador snow crab fishery have submitted their price recommendations.
Now, they wait.
In a social media post on Sunday, the Fish Food and Allied Workers union said the price setting panel hearing on snow crab began that morning.
The union is asking the panel for a starting price of $4.97 per pound this season.
In the same post, the union said the Association of Seafood Producers is asking the panel for a starting price of $4.50 per pound.
"Everyone hears about $5, $6, even $7 crab, so nobody is terribly thrilled at the idea of $4.97, and even less thrilled at the idea of $4.50," said Ray Critch, a negotiator and policy manager for the FFAW.
"But just to make sure that floor is there should there be a bit of softness in the market, we wanted to make sure it was a reasonable floor that the panel would be more likely to accept rather than what we think are the deflated — artificially deflated — prices from the ASP."
No one from the ASP was available for an interview.
The snow crab fishery is the province's most lucrative fishery — worth about $476 million in 2024 — and also one of its most fraught.
Last year, a price dispute led to violent protests outside of Confederation Building in St. John's, and forced the province to delay the annual budget.
Last month, the Department of Fisheries and Oceans increased the total allowable catch by nine per cent, but cut the quota in division 3K — down almost 25 per cent to 7,643 tonnes — and in subdivision 3Ps by about 16 per cent.
In response, harvesters protested at the office of federal Fisheries Minister Joanne Thompson, and the St. John's Convention Centre, where Liberal Leader Mark Carney was campaigning.
The DFO ultimately did not back away from the quota cuts.
Meanwhile, the price setting panel is considering both offers against the backdrop of an ongoing Canada-U.S. trade war.
Jeff Loder, the executive director of the ASP, has said they're proposing two prices, depending on whether or not the U.S. enacts tariffs.
WATCH | FFAW negotiator talks about the unions tariff planning:
FFAW snow crab submission includes tariff contingency plans
5 hours ago
Duration 0:46
Panel hearings on snow crab prices are happening now. But this year, they're happening in the shadow of a trade war. Both the Fish, Food and Allied Workers union and the Association of Seafood Producers are taking tariff threats into account.
Critch says the FFAW has "built in a direct tariff proposal" and that if there are tariffs then harvesters would agree to accept 30 per cent of any tariff that's out there.
"The distributors, and more importantly the consumers, will likely also have to bear some of the burden of tariffs," he said. "Perhaps more importantly, we also included a clause that says if the bottom really does drop out of the economy and the season … that would automatically bring everybody back to the table to renegotiate."
The panel should make a decision on price on Wednesday — the same day the ASP, the FFAW and the Newfoundland and Labrador government will be in court to hear a decision on whether the province's fisheries minister had the authority to change a key date for this year's fishery without consulting both the union and processors.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Globe and Mail
10 minutes ago
- Globe and Mail
ZYUS Life Sciences Announces Closing of Second Tranche of Unit Offering
SASKATOON, SK , Aug. 15, 2025 /CNW/ - ZYUS Life Sciences Corporation (the " Company") (TSXV: ZYUS), a Canadian-based life sciences company focused on the development and commercialization of novel cannabinoid-based pharmaceutical drug candidates for pain management, is pleased to announce that, further to its press release dated July 29, 2025, it has closed the second tranche (the " Second Tranche") of its non-brokered private placement (the " Offering") of units of the Company (each a " Unit") for up to CAD $1,000,000 . Under the Second Tranche of the Offering, a further 140,845 Units were issued for aggregate gross proceeds of CAD $100,000 . The aggregate gross proceeds raised in the Second Tranche and first tranche of the Offering (which closed on July 29, 2025) (the " First Tranche") is approximately $0.42 million. The Company has issued a total of 591,126 Units each priced at $0.71 per Unit in the First Tranche and the Second Tranche. Each Unit consists of one common share of the Company (a " Common Share") and one Common Share purchase warrant (each Common Share purchase warrant, a " Warrant"), whereby each Warrant entitles the holder to acquire one Common Share at a price of $0.95 for a period of twenty-four months from the date of issuance, unless the term of the Warrant is accelerated pursuant to its terms (the " Acceleration Provision"). In accordance with the Acceleration Provision, if the volume-weighted average trading price of the Common Shares is greater than $3.00 for a period of 5 consecutive trading days on the TSX Venture Exchange (the " TSXV"), the Company will have the right to accelerate the expiry date of the Warrants. Proceeds of the Offering will be used for general corporate and working capital purposes. No finder's fees were paid in connection with the Offering. The Units were offered by way of private placement pursuant to exemptions from prospectus requirements under applicable securities laws. All securities issued under the First Tranche are subject to a hold period expiring November 30, 2025 , and all securities issued under the Second Tranche of the Offering are subject to a hold period expiring December 16, 2025 , in accordance with applicable securities laws and the policies of the TSXV. The Offering has received conditional approval from the TSXV and remains subject to final acceptance of the TSXV. The securities described herein have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the " U.S. Securities Act"), or any state securities laws, and may not be offered or sold within the United States or to, or for account or benefit of, U.S. persons except in compliance with the registration requirements of the U.S. Securities Act and applicable state securities laws or pursuant to available exemptions therefrom. This release does not constitute an offer to sell or a solicitation of an offer to buy of any securities in the United States. About ZYUS Life Sciences Corporation ZYUS (TSXV: ZYUS) is a life sciences company focused on the development and commercialization of novel cannabinoid-based pharmaceutical drug candidates for pain management. Through rigorous scientific exploration and clinical research, ZYUS aims to secure intellectual property protection, safeguarding its innovative therapies and bolstering shareholder value. ZYUS' unwavering commitment extends to obtaining regulatory approval of non-opioid-based pharmaceutical solutions, in pursuit of transformational impact on patients' lives. For additional information, visit or follow us on X @ZYUSCorp. Cautionary Note Regarding Forward-Looking Statements This news release contains "forward-looking information" within the meaning of applicable securities laws relating to the Company's business, the Company's ability to advance clinical research activities, obtain regulatory approval of cannabinoid-based pharmaceutical drug candidates and introduce products that act as alternatives to current pain management therapies such as opioids, receipt of TSXV final acceptance, closing of any additional tranche of the Offering and use of proceeds from the Offering. Any such forward-looking statements may be identified by words such as "expects", "anticipates", "intends", "contemplates", "believes", "projects", "plans", "will" and similar expressions. Readers are cautioned not to place undue reliance on forward-looking statements. Statements about, among other things, the Company's business, the Company's ability to advance clinical research activities, obtain regulatory approval of cannabinoid-based pharmaceutical drug candidates and introduce products that act as alternatives to current pain management therapies such as opioids, obtain TSXV final acceptance, closing of any additional tranche of the Offering and use of proceeds from the Offering are all forward-looking information. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management's reasonable assumptions, there can be no assurance that the Company will be able to achieve these results. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances or actual results unless required by applicable law. Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this press release.


CBC
10 minutes ago
- CBC
Burnaby company pitches plan to heat Kits Pool with bitcoin mining
A Burnaby company is proposing to heat Kitsilano Pool with excess heat from bitcoin mining. A UBC professor says the plan is energy inefficient, bad for Kits Pool, and bitcoin is a "slow-burning Ponzi scheme" with "no other use than to facilitate fraud, scams, and money laundering."


CBC
27 minutes ago
- CBC
Stellantis lays off 'small number' of workers in Windsor as company cuts back on EV muscle car
Stellantis is laying off workers at its assembly plant in Windsor, Ont., as the company shifts away from its electric muscle car. "A small number" of workers received layoff notices Friday, according to Stellantis spokesperson LouAnn Gosselin. "The layoffs are based on seniority and are a result of regular volume adjustments at the plant," Gosselin said. The company would not confirm the number of impacted employees. The union representing the plant's workers did not respond to a request for comment. The news comes on the last day of work before the plant's regular summer shutdown. It also comes at a time of heightened anxiety for auto workers in Canada, especially those in Windsor, where the economy relies heavily on the industry. Workers optimistic Employees at the Windsor assembly plant have faced temporary layoffs in recent months as a result of U.S. President Donald Trump's trade war with Canada and levies on the auto sector — though carve-outs for products that comply with CUSMA, the countries' existing trade deal, have softened the blow. The handful of workers who spoke to CBC Friday outside the Windsor assembly plant said they expect workers to be back on the job before long. "Could be a couple weeks," Emanuele Caruana said. "Right now things aren't looking too good, but they're going to be good soon." Dixon Bell described the layoffs as "not good" but said he too believed workers would be brought back eventually. Dave Lumley isn't worried at all, he said, and predicted the workers would be back on the job before Christmas. "It's just temporary," he said. "It's just a small amount. That happens a lot. It comes and goes. It's only 100 people." Lumley attributed the layoffs to changes in Dodge Charger production at the plant. "We have a battery area, and … we're not building batteries," he said. "Everybody wants gas, so they're trying to transition. That's mainly what it is." In May, Stellantis announced that it was postponing production of the Dodge Charger Daytona R/T, the base model of the first-of-their-kind electrified muscle cars, just a year after introducing them with great fanfare. The global automaker has blamed U.S. tariffs for the decision, but the move also followed weak sales amid a dampening EV market. Workers at the Windsor plant assemble both the Chargers and the company's minivan offerings, including the Chrysler Pacifica. Last week, Stellantis unveiled the 2026 Dodge Charger Scat Pack, equipped with an inline-six twin turbo engine, after months of pleading from gear heads to bring back gas-powered versions of the previously popular muscle cars.